Location of Repository

MEIS and PBX homeobox proteins in ovarian cancer

By E.G. de Vries, A.G. van der Zee, A.P. Crijns, P. de Graeff, D. Geerts, K.A. ten Hoor, H. Hollema, T. van der Sluis, R.M. Hofstra, G.H. de Bock and S. de Jong


Three amino-acid loop extension (TALE) homeobox proteins MEIS and PBX are cofactors for HOX-class homeobox proteins, which control growth and differentiation during embryogenesis and homeostasis. We showed that MEIS and PBX expression are related to cisplatin resistance in ovarian cancer cell lines. Therefore, MEIS1, MEIS2 and PBX expression were investigated immunohistochemically in a tissue microarray (N=232) of ovarian cancers and ovarian surface epithelium (N=15). Results were related to clinicopathologic characteristics and survival. All cancers expressed MEIS1, MEIS2 and PBX in nucleus and cytoplasm. MEIS1 and 2 only stained nuclear in surface epithelium. Nuclear MEIS2 was negatively related to stage, grade and overall survival in univariate analyses. Additionally, MEIS and PBX RNA expression in ovarian surface epithelium and other normal tissues and ovarian cancer versus other tumour types using public array data sets were studied. In ovarian cancer, MEIS1 is highly expressed compared to other cancer types. In conclusion, MEIS and PBX are extensively expressed in ovarian carcinomas and may play a role in ovarian carcinogenesis

Year: 2007
OAI identifier: oai:ub.rug.nl:dbi/497f097085ff4
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://share.eldoc.ub.rug.nl/r... (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.